Trusted Resource for Clinical Trials, Protocols & Progress
ECs safeguard the rights and safety of clinical trial participants. They review protocols, informed consent forms (ICFs), and other essential documents to ensure ethical conduct. As per CDSCO and USFDA regulations, no human subject research can begin without EC approval. Hence, a clean and complete submission is essential to keep your project on track.
Click to read the full article.
There are generally two models for EC oversight in multicenter studies:
Click to read the full article.
A robust, readable, and compliant Informed Consent Form significantly improves your chances of Ethics Committee approval. By using this checklist and adhering to regulatory and EC-specific expectations, you ensure ethical clarity for participants while avoiding resubmissions and costly delays. Document all changes, validate translations, and maintain centralized version control to stay EC-ready at all times.
Click to read the full article.
According to USFDA and ICH-GCP E6(R2) guidelines, vulnerable populations include individuals who may have limited capacity or freedom to give informed consent. These groups often require additional ethical scrutiny before enrollment in research.
Click to read the full article.
Ethics Committees play a pivotal role in safeguarding child participants:
Click to read the full article.
They include individuals with limited capacity to understand, evaluate, or communicate informed decisions due to neurodegenerative, psychiatric, or developmental disorders. Examples include:
Click to read the full article.
Research involving prisoners or institutionalized individuals must be submitted to Ethics Committees (ECs) with additional documentation and safeguards:
Click to read the full article.
In rare emergency or non-interventional observational studies:
Click to read the full article.
A Legally Authorized Representative is an individual or entity permitted under applicable law to consent on behalf of a prospective subject who is unable to provide informed consent. LARs may include:
Click to read the full article.
High-risk vulnerable populations require more than standard safety measures. Enhanced monitoring, ethical oversight, and proactive risk mitigation are essential. With the right infrastructure, training, and commitment to participant welfare, clinical research in these populations can uphold the highest ethical and scientific standards.
Click to read the full article.
